that a trial is delayed costs the sponsor:
in operational costs
in lost opportunity costs
not to mention patent depreciation costs.
These economic losses can be largely attributed to inefficiencies in the clinical trial recruitment process. We have combined the power of
to shorten the durations of clinical research.
Capitalizing on the A.I. technology of Aspen Insights and connections with various EMRs allows us to target patients for trial recruitment based on a multitude of health and biographical dimensions, yeilding enrollment rates far above current market expectations.
See if we can reduce your clinical research costs by requesting trial feasibility results generated from our proprietary algorithms.